logo

For the Inventor, By the Inventor

CA

Lorus Therapeutics Inc.

USPTO Granted Patents = 10

% Expired Patents = 70.0



Trademarks = 1

Forward Citations = 50

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Aiping H Young (7 out of 19 patents)

silverMedal Yoon S Lee (5 out of 11 patents)

bronzeMedal Mario Huesca (4 out of 7 patents)

4.  Jim A Wright (4 out of 12 patents)

5.  Romeo G Rang (3 out of 3 patents)

6.  Raed Al-Qawasmeh (2 out of 4 patents)

7.  Lisa Lock (1 out of 2 patents)

8.  Howard Cukier (1 out of 1 patent)

9.  Venkata Nedunuri (1 out of 1 patent)

10.  Robert Peralta (1 out of 1 patent)

11.  Raed H Al-Qawasmeh (1 out of 2 patents)

12.  Ming Yu Cao (1 out of 1 patent)

13.  Aye Aye Khine (1 out of 1 patent)

14.  Paul B Percheson (1 out of 1 patent)

15.  Yoon Lee (0 patent)


10 patents:

1. 9309247 - 2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer (2016-04-12),
2. 8394815 - 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents (2013-03-12),
3. 8287851 - Use of interleukin 17E for the treatment of cancer (2012-10-16),
4. 8148392 - 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer (2012-04-03),
5. 7968526 - Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer (2011-06-28),
6. 7884120 - 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents (2011-02-08),
7. 7405205 - Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase (2008-07-29),
8. 6596319 - Immunomodulating compositions for treatment of immune system disorders (2003-07-22),
9. 6551623 - Immunomodulating compositions from bile (2003-04-22),
10. 6280774 - Immunomodulating compositions from bile (2001-08-28),
Company Overview
Lorus Therapeutics Inc. is a biotechnology company based in Canada, focused on the development of innovative therapies for cancer treatment. The company specializes in the research and advancement of novel therapeutic agents that target specific cancer pathways, aiming to improve patient outcomes. With a commitment to harnessing cutting-edge science, Lorus Therapeutics is dedicated to addressing unmet medical needs in oncology through its proprietary drug development programs.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#135 in

#1,525 in Canada

#56,092 in the World

CA
CA

Lorus Therapeutics Inc.

Forward Citations = 50

14 inventors:

goldMedal Aiping H Young (7 out of 19 patents)

silverMedal Yoon S Lee (5 out of 11 patents)

bronzeMedal Mario Huesca (4 out of 7 patents)

4.  Jim A Wright (4 out of 12 patents)

5.  Romeo G Rang (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lorus Therapeutics Inc.. Retrieved from https://idiyas.com/company/lorus-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…